206 related articles for article (PubMed ID: 30586470)
1. Evaluation of combined idarucizumab and prothrombin complex concentrate treatment for bleeding related to dabigatran in a lethal porcine model of double trauma.
Honickel M; Braunschweig T; Rossaint R; Schöchl H; Grottke O
Transfusion; 2019 Apr; 59(4):1376-1387. PubMed ID: 30586470
[TBL] [Abstract][Full Text] [Related]
2. Reversing Dabigatran Anticoagulation with Prothrombin Complex Concentrate versus Idarucizumab as Part of Multimodal Hemostatic Intervention in an Animal Model of Polytrauma.
Honickel M; Braunschweig T; Rossaint R; Stoppe C; Ten Cate H; Grottke O
Anesthesiology; 2017 Nov; 127(5):852-861. PubMed ID: 28857806
[TBL] [Abstract][Full Text] [Related]
3. Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.
Honickel M; Treutler S; van Ryn J; Tillmann S; Rossaint R; Grottke O
Thromb Haemost; 2015 Apr; 113(4):728-40. PubMed ID: 25567155
[TBL] [Abstract][Full Text] [Related]
4. Therapy with activated prothrombin complex concentrate is effective in reducing dabigatran-associated blood loss in a porcine polytrauma model.
Honickel M; Maron B; van Ryn J; Braunschweig T; ten Cate H; Spronk HM; Rossaint R; Grottke O
Thromb Haemost; 2016 Jan; 115(2):271-84. PubMed ID: 26333775
[TBL] [Abstract][Full Text] [Related]
5. Dose requirements for idarucizumab reversal of dabigatran in a lethal porcine trauma model with continuous bleeding.
Honickel M; Spronk HM; Rossaint R; Stoppe C; van Ryn J; Ten Cate H; Grottke O
Thromb Haemost; 2017 Jun; 117(7):1370-1378. PubMed ID: 28424818
[TBL] [Abstract][Full Text] [Related]
6. Prothrombin Complex Concentrate Is Effective in Treating the Anticoagulant Effects of Dabigatran in a Porcine Polytrauma Model.
Honickel M; Braunschweig T; van Ryn J; Ten Cate H; Spronk HM; Rossaint R; Grottke O
Anesthesiology; 2015 Dec; 123(6):1350-61. PubMed ID: 26414500
[TBL] [Abstract][Full Text] [Related]
7. Reversal of dabigatran by intraosseous or intravenous idarucizumab in a porcine polytrauma model.
Akman N; Braunschweig T; Honickel M; Schütt K; Schöchl H; Stoppe C; Rossaint R; Grottke O
Br J Anaesth; 2018 May; 120(5):978-987. PubMed ID: 29661415
[TBL] [Abstract][Full Text] [Related]
8. Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model.
Grottke O; van Ryn J; Spronk HM; Rossaint R
Crit Care; 2014 Feb; 18(1):R27. PubMed ID: 24499559
[TBL] [Abstract][Full Text] [Related]
9. Prothrombin Complex Concentrate-induced Disseminated Intravascular Coagulation Can Be Prevented by Coadministering Antithrombin in a Porcine Trauma Model.
Grottke O; Honickel M; Braunschweig T; Reichel A; Schöchl H; Rossaint R
Anesthesiology; 2019 Sep; 131(3):543-554. PubMed ID: 31180918
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation.
Grottke O; Aisenberg J; Bernstein R; Goldstein P; Huisman MV; Jamieson DG; Levy JH; Pollack CV; Spyropoulos AC; Steiner T; Del Zoppo GJ; Eikelboom J
Crit Care; 2016 Apr; 20(1):115. PubMed ID: 27125504
[TBL] [Abstract][Full Text] [Related]
11. Reversing the anticoagulation effects of dabigatran.
Dager WE; Banares L
Hosp Pract (1995); 2017 Apr; 45(2):29-38. PubMed ID: 28335637
[TBL] [Abstract][Full Text] [Related]
12. Reversal of Anticoagulation With Dabigatran in an 82-Year-Old Patient With Traumatic Retroperitoneal Arterial Bleeding Using the New Antidote Idarucizumab: A Case Report.
Hofer S; Philipsenburg C; Weigand MA; Brenner T
A A Case Rep; 2016 Dec; 7(11):227-231. PubMed ID: 27669031
[TBL] [Abstract][Full Text] [Related]
13. Prothrombin complex concentrate reduces blood loss and enhances thrombin generation in a pig model with blunt liver injury under severe hypothermia.
Honickel M; Rieg A; Rossaint R; Braunschweig T; Spronk HM; ten Cate H; van Oerle R; Tolba R; Grottke O
Thromb Haemost; 2011 Oct; 106(4):724-33. PubMed ID: 21901227
[TBL] [Abstract][Full Text] [Related]
14. Reversal of dabigatran effects in models of thrombin generation and hemostasis by factor VIIa and prothrombin complex concentrate.
Hoffman M; Volovyk Z; Monroe DM
Anesthesiology; 2015 Feb; 122(2):353-62. PubMed ID: 25502064
[TBL] [Abstract][Full Text] [Related]
15. Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.
Glund S; Stangier J; Schmohl M; Gansser D; Norris S; van Ryn J; Lang B; Ramael S; Moschetti V; Gruenenfelder F; Reilly P; Kreuzer J
Lancet; 2015 Aug; 386(9994):680-90. PubMed ID: 26088268
[TBL] [Abstract][Full Text] [Related]
16. Reversal or Repletion Treatment Strategies and Outcomes of Patients With Major Bleeding Events Managed in the Emergency Department: Large Real-Life Investigation in the Northwestern Healthcare District of Tuscany.
Conti A; Leorin M; Bogazzi IC; Renzi N; Pepe G; Frosini F; Furesi L; Dalla Tomasina L; Pennati P; Ghiadoni L;
Crit Pathw Cardiol; 2024 Jun; 23(2):58-72. PubMed ID: 38781079
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic safety of prothrombin complex concentrate (Beriplex P/N) for dabigatran reversal in a rabbit model.
Herzog E; Kaspereit FJ; Krege W; Doerr B; van Ryn J; Dickneite G; Pragst I
Thromb Res; 2014 Sep; 134(3):729-36. PubMed ID: 25084749
[TBL] [Abstract][Full Text] [Related]
18. Management of dabigatran after overdosage: two case reports and suggestions for monitoring.
Billoir P; Girault C; Barbay V; Boyer D; Grangé S; Fresel M; Chrétien MH; Le Cam Duchez V
Blood Coagul Fibrinolysis; 2018 Nov; 29(7):653-655. PubMed ID: 30045050
[TBL] [Abstract][Full Text] [Related]
19. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
Eerenberg ES; Kamphuisen PW; Sijpkens MK; Meijers JC; Buller HR; Levi M
Circulation; 2011 Oct; 124(14):1573-9. PubMed ID: 21900088
[TBL] [Abstract][Full Text] [Related]
20. Cholestatic liver injury as a side-effect of dabigatran and the use of coagulation tests in dabigatran intoxication and after reversal by idarucizumab in bleeding and sepsis.
Comuth WJ; Haase AM; Henriksen LØ; Malczynski J; van de Kerkhof D; Münster AB
Scand J Clin Lab Invest; 2018; 78(1-2):1-5. PubMed ID: 29148292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]